Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 35.18 CNY | +0.14% |
|
-0.06% | -22.88% |
| Market Cap | 23.43B 3.49B 3.07B 2.9B 2.63B 4.94B 335B 4.97B 34.75B 13.42B 171B 13.1B 12.82B 549B | P/E 2026 * |
26.3x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 23.43B 3.49B 3.07B 2.9B 2.63B 4.94B 335B 4.97B 34.75B 13.42B 171B 13.1B 12.82B 549B | EV / Sales 2026 * |
4.75x | EV / Sales 2027 * | 4.38x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.14% | ||
| 1 week | -0.06% | ||
| Current month | -2.39% | ||
| 1 month | -3.43% | ||
| 3 months | -0.90% | ||
| 6 months | -20.08% | ||
| Current year | -22.88% |
| 1 week | 34.8 |  | 35.68 |
| 1 month | 33.83 | | 36.63 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 2026-09-03 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | -0.06% | -19.70% | -3.43% | 3.49B | |
| +0.92% | -1.49% | -11.87% | -5.57% | 13.38B | |
| -0.04% | -1.39% | -31.78% | -57.41% | 4.77B | |
| +0.29% | -0.70% | -4.83% | -7.70% | 4.3B | |
| +0.07% | -2.82% | -4.17% | -35.42% | 3.77B | |
| +1.02% | -1.20% | -0.88% | -9.80% | 3.39B | |
| +0.88% | -1.92% | -12.16% | -4.96% | 3.07B | |
| -0.34% | -2.03% | -20.76% | -19.25% | 2.24B | |
| -0.46% | -3.07% | -25.72% | -25.92% | 1.63B | |
| +0.95% | -2.97% | -2.30% | -24.78% | 1.61B | |
| Average | +0.34% | -1.76% | -13.42% | -19.43% | 4.16B | |
| Weighted average by Cap. | +0.49% | -1.55% | -13.16% | -16.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 734M 646M 611M 554M 1.04B 70.5B 1.05B 7.31B 2.82B 35.97B 2.76B 2.7B 116B | 5.35B 797M 701M 663M 601M 1.13B 76.51B 1.14B 7.94B 3.07B 39.04B 2.99B 2.93B 125B |
| Net income | 1.04B 154M 136M 128M 116M 219M 14.81B 220M 1.54B 593M 7.56B 579M 567M 24.29B | 1.18B 176M 155M 147M 133M 250M 16.93B 251M 1.76B 678M 8.64B 662M 648M 27.76B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | CN¥35.18 | +0.14% | 1,682,163 |
| 26-09-24 | CN¥35.13 | -0.73% | 1,495,477 |
| 26-09-23 | CN¥35.39 | +0.83% | 1,586,212 |
| 26-09-22 | CN¥35.10 | -0.28% | 1,366,366 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.18
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
